Fluid Teardowns — Nº 002
6M devices sold.
$103M on TikTok.
Off one $259 gadget.
Medicube turned a $259 skincare gadget into the top-selling beauty brand on TikTok Shop — and dragged an entire routine of serums along with it. We pulled their sales, their ads, and their storefront. Here's the teardown.
A $259 skincare gadget outsells every serum around it — and pulls those serums into the cart with it. That's the first thing that should stop you about Medicube. Most beauty brands lead with a hero cream. Medicube leads with a device, then builds an entire routine designed to be used with it. For any brand that sells a device — the model looks awfully familiar.
By the end you'll have the seven plays behind a K-beauty juggernaut that did $103 million on TikTok Shop and sold 6 million devices worldwide — each with a "steal this" you can run tomorrow.
The receipts — US storefront, climbing
Fluid Intelligence Desk · June 2026 · USDA "medical" gadget from Seoul, engineered for TikTok.
Medicube is the flagship brand of APR Corp, a Seoul beauty-tech company that rode the K-beauty wave to a blockbuster IPO — its founder became a paper billionaire on the back of TikTok buzz. The brand's whole identity is in the logo lockup: "medicube — K-Beauty Tech." Not a cream company. A device company that happens to sell serums.
That framing is the strategy. Parent APR grew revenue 123% year-on-year in Q1 2026, and now earns roughly 90% of revenue overseas, with the US its fastest-growing market. The engine underneath it all:
"A demo-able product doesn't need a channel. It needs a stage."The Medicube operating principle
Their storefront, captured live.
Seven plays every device brand should copy.
Make the device the hero
Medicube's #1 revenue product isn't a serum — it's the Booster Pro X2, a $259 microcurrent-and-LED device. Cumulatively, Age-R devices have sold over 6 million units. The gadget is the highest-ticket, highest-status entry point, and everything else in the catalog exists to orbit it. Lead with the hardware, and the brand instantly reads as "tech," not "another cream."
Put your device on the marquee, not buried in a "tools" tab. It's your most defensible, highest-margin, most screenshot-worthy asset — make it the face of the brand.
Razor-and-blades: the device sells the routine
Here's the compounding move. The Booster Pro X2 is a one-time, high-ticket buy — but it only works paired with serums and creams "to boost absorption." So a $259 device purchase pulls the customer into a repeat-purchase ecosystem: PDRN serum, collagen cream, pore pads, all designed to be used with the device. One gadget sale becomes a subscription in disguise.
Design consumables that are required to get the most from your device. The hardware wins the customer; the refills keep them. That's the whole razor-and-blades engine.
Surf the ingredient wave — PDRN "salmon DNA"
PDRN — marketed as "salmon DNA" — became the viral K-beauty molecule of the moment, and Medicube built a whole pink line around it. The serum doesn't hide the science; it puts it on the label as a badge. It's the same move as any great trend-surf: name the thing the customer is already curious about, right on the box. Straight from the bottle:
Find the ingredient your market is already searching — then make it the product name, not a footnote. The trend does your explaining for you.
Win on demonstration, not description
You can't sell a device with a spec sheet — you sell it by showing it work. Medicube leans entirely on proof you can watch: before-and-afters, glass-skin glow-ups, and full device masterclasses (a Booster Pro X2 session with "Dr. Fab" for editors and influencers in London). Every asset answers one question: what does it do to a real face?
Your device needs a demo, an expert, and a visible before/after — in that order. Show the transformation; skip the technology lecture.
Sell in the same breath as the demo
Here's the mechanic underneath the numbers. Medicube never makes you leave the demo to go buy — the second you watch the device work, the buy button is right there. That collapse of demonstration and checkout did $102.9M and 1M+ units, and the Booster Pro X2 launched into a shoppable video before it ever hit a shelf. The lesson isn't "go rent a marketplace" — it's that a demo-able product should be buyable the instant it's shown, on a surface you control.
One tracked week of drops
Seven days, seven drops — devices, lines, and format extensions, feeding the feed non-stop.
Collapse the distance between "watch the demo" and "buy now." Wherever your team demos — live, in content, in the field — the checkout should be one tap away on a storefront you own, not a marketplace you rent. That's leverage you keep.
Launch like a media company
Look at that week again: a new device promo, a new line, a fragrance mist, a hair mask — almost every single day. Medicube treats its ingredient "lines" (PDRN, Zero, Glow, Deep, Kojic Acid) as franchises it can keep extending: PDRN skincare becomes PDRN hair, becomes a limited-edition set. Every drop is a fresh reason to post, to reorder, and to go viral — off a catalog that's really just a handful of hero lines.
Turn your best ingredient into a line, then extend it into new formats on a drumbeat. New format, new hero, new content — without inventing a new brand.
Cash the viral demand at retail
The final move: convert TikTok heat into shelf space. On the back of the viral run, Medicube rolled into Lookfantastic and 1,400 Ulta Beauty doors across the US in a matter of months, while parent APR pushed toward 90% overseas revenue. The organic proof shows in the data too — their posts average 2,641 likes, roughly 8x a typical DTC supplement brand. Viral built the demand; retail cashed it.
Use the viral channel to manufacture demand, then walk into the retail buyer's office with the numbers. TikTok earns the shelf; the shelf legitimizes everything.
The part most breakdowns skip…
"K-Beauty Tech" is a claim you have to back.
Be clear-eyed. Framing a $259 gadget as medical-grade "tech," and a serum as "salmon DNA," is brilliant positioning — and it lives in a scrutinized zone. At-home beauty devices that imply clinical results draw FDA attention, and PDRN's topical benefits are still emerging science, not settled fact. Novel-ingredient and device-efficacy claims are exactly what regulators and skeptics probe first. The lesson isn't "don't sell the sizzle" — it's that a tech-forward claim buys attention and obligation. If you run this play, keep the demo honest and the fine print real.
Tear off this page.
The Medicube playbook on one screen.
This is the device playbook. Fluid is how you run it.
A device as the hero, a routine engineered around it, demo-first content, and a channel where the demo is the checkout — every play here is an operating-system problem. That's what we build.